GE HEALTHCARE : UBS downgrades

 UBS downgrades its recommendation on GE Healthcare Technologies from 'neutral' to 'sell', with a price target reduced from $86 to $66. This new target implies a potential downside of 10% for the US medical equipment supplier's stock.

Weak orders, difficult comparatives and a lack of price increases put us below the 2024 consensus, while a more cautious approach to imaging margin puts us below this," says the broker.

https://www.marketscreener.com/quote/stock/GE-HEALTHCARE-TECHNOLOGIE-148175835/news/GE-Healthcare-UBS-downgrades-its-recommendation-45440906/